Securing non-dilutive capital can be the key to bridging the gap between research and commercial reality for agtech startups. Matt Dobbs shares how AgSenze leveraged grant programmes including Innovate UK and EU Horizon to de-risk R&D, unlock private investment, and provide a launchpad of scaling HerdVision.

When innovation moves faster than policy, the path to market calls for creative approaches. Tammie Wahaus, CEO of ELIAS Animal Health, shares how her team advances pivotal trials, adapts human health technologies, and keeps development on track as regulatory expectations continue to evolve.

Scaling livestock technology requires uniting innovation with effective distribution and farmer adoption. David Smith outlines how Ceres Tag’s open platform empowers universities, distributors, and next-generation producers to accelerate global adoption and data-driven impact.